The panel closes their discussions by highlighting current unmet needs in multiple myeloma treatment and what excites them on the horizon.
Navigating AE Management for Cellular Therapy Across Hematologic Cancers
A panel of clinical pharmacists discussed strategies for mitigating toxicities across different multiple myeloma, lymphoma, and leukemia populations.